- Home
- PFE
PFE
Pfizer Inc.
as 06-20-2025 4:00pm EST
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 134.2B | IPO Year: | N/A |
| Target Price: | $29.92 | AVG Volume (30 days): | 37.0M |
| Analyst Decision: | Hold | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $20.91 - $31.54 | Next Earning Date: | 07-29-2025 |
| Revenue: | $62,464,000,000 | Revenue Growth: | 11.65% |
| Revenue Growth (this year): | -0.91% | Revenue Growth (next year): | -0.34% |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Lantheus Holdings (NasdaqGM:LNTH) Joins FIBRE Consortium To Transform Fibrotic Disease Treatment
Simply Wall St.
a day ago
Pfizer (NYSE:PFE) Joins FIBRE Consortium To Advance Fibrosis Treatment Through Innovative Imaging
Barrons.com
a day ago
Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.
Zacks
a day ago
Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?
Zacks
a day ago
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Simply Wall St.
2 days ago
The past three years for Pfizer (NYSE:PFE) investors has not been profitable
Zacks
2 days ago
Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?
Barrons.com
2 days ago
Gene Therapy Has Lost Support on Wall Street. There’s Still Hope for Big Cures.
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.